JW Shinyak Corp
067290
Company Profile
Business description
JW Shinyak Corp is a pharmaceutical company focused on manufacturing and selling pharmaceuticals, operates within the pharmaceutical industry ecosystem. The group operates in the fields of dermatology, urology, and otolaryngology.
Contact
38 Gwacheon-daero 7-gil
Gyeonggi-do
Galhyeon-dong
Gwacheon-si
KORT: +82 28406871
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
190
Stocks News & Analysis
stocks
Are declining Chinese births a red flag for A2 Milk?
Demographic challenges in A2’s largest market lead to sell-off.
stocks
Is this ASX share a value trap or bargain?
Cost-cutting the priority as underlying asset values falling on deaf ears.
stocks
Goldman Sachs Earnings: Valuations remain stretched
We raise our fair value estimate for Goldman Sachs stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,108.60 | 16.20 | 0.18% |
| CAC 40 | 8,079.17 | 16.59 | 0.21% |
| DAX 40 | 24,559.86 | 143.26 | -0.58% |
| Dow JONES (US) | 48,747.01 | 258.42 | 0.53% |
| FTSE 100 | 10,151.04 | 24.26 | 0.24% |
| HKSE | 26,585.06 | 97.55 | 0.37% |
| NASDAQ | 23,090.65 | 136.33 | 0.59% |
| Nikkei 225 | 52,774.64 | 216.46 | -0.41% |
| NZX 50 Index | 13,417.17 | 156.76 | -1.15% |
| S&P 500 | 6,840.56 | 43.70 | 0.64% |
| S&P/ASX 200 | 8,782.90 | 14.00 | 0.16% |
| SSE Composite Index | 4,116.94 | 3.29 | 0.08% |